CardiOCare's project logo

An Interdisciplinary Approach for the Management of the Elderly Multimorbid Patient with Breast Cancer Therapy Induced Cardiac Toxicity

CARDIOCARE Study Reaches a Milestone with Recruitment of 340 Multimorbid Elderly Breast Cancer Patients

Sep 10, 2024

We are pleased to announce a significant achievement in the CARDIOCARE clinical study, which focuses on multimorbid elderly breast cancer patients. Our research is dedicated to assessing the impact of behavioral and psychological interventions on improving patients’ quality of life, as well as their physical and mental wellbeing. Additionally, the study closely monitors the cardiotoxic effects of breast cancer treatments, a critical aspect of patient care.

The recruitment phase, happening across 5 countries in Italy 🇮🇹, Cyprus 🇨🇾, Sweden 🇸🇪, Greece 🇬🇷, and Slovenia 🇸🇮, in 6 clinical centres, has successfully enrolled 340 patients. This milestone is a testament to the dedication of our team and the collaboration across countries, moving us closer to our goal of enhancing the healthcare journey for breast cancer patients.

As we continue to make strides in this important study, we remain committed to providing personalized support for these vulnerable patients.

Stay tuned for more updates as the CARDIOCARE project progresses!

Highlights

CARDIOCARE participates in the 45th Hellenic Congress of Cardiology

CARDIOCARE participates in the 45th Hellenic Congress of Cardiology

CARDIOCARE is proud to have participated in the 45th Hellenic Congress of Cardiology, held from October 31st to November 2nd, 2024, in the stunning locale of Hersonissos, Crete, Greece. This esteemed congress served as a pivotal platform for healthcare professionals,...

Prof. Fotiadis shares pioneering insights at MDBS-BHE 2024

Prof. Fotiadis shares pioneering insights at MDBS-BHE 2024

Prof. Dimitrios Fotiadis, UOI & coordinator of the CARDIOCARE project, recently participated in the 22nd International Symposium on Medical Devices and Biosensors (MDBS 2024), held in hybrid mode in China from November 20 to 22, 2024, in conjunction with the 15th...